405 related articles for article (PubMed ID: 27486820)
21. TAM Family Receptor Kinase Inhibition Reverses MDSC-Mediated Suppression and Augments Anti-PD-1 Therapy in Melanoma.
Holtzhausen A; Harris W; Ubil E; Hunter DM; Zhao J; Zhang Y; Zhang D; Liu Q; Wang X; Graham DK; Frye SV; Earp HS
Cancer Immunol Res; 2019 Oct; 7(10):1672-1686. PubMed ID: 31451482
[TBL] [Abstract][Full Text] [Related]
22. The receptor tyrosine kinase AXL promotes migration and invasion in colorectal cancer.
Uribe DJ; Mandell EK; Watson A; Martinez JD; Leighton JA; Ghosh S; Rothlin CV
PLoS One; 2017; 12(7):e0179979. PubMed ID: 28727830
[TBL] [Abstract][Full Text] [Related]
23. Gas6 deficiency increases oligodendrocyte loss and microglial activation in response to cuprizone-induced demyelination.
Binder MD; Cate HS; Prieto AL; Kemper D; Butzkueven H; Gresle MM; Cipriani T; Jokubaitis VG; Carmeliet P; Kilpatrick TJ
J Neurosci; 2008 May; 28(20):5195-206. PubMed ID: 18480276
[TBL] [Abstract][Full Text] [Related]
24. AXL is an oncotarget in human colorectal cancer.
Martinelli E; Martini G; Cardone C; Troiani T; Liguori G; Vitagliano D; Napolitano S; Morgillo F; Rinaldi B; Melillo RM; Liotti F; Nappi A; Bianco R; Berrino L; Ciuffreda LP; Ciardiello D; Iaffaioli V; Botti G; Ferraiolo F; Ciardiello F
Oncotarget; 2015 Sep; 6(27):23281-96. PubMed ID: 25966280
[TBL] [Abstract][Full Text] [Related]
25. Activation of TYRO3/AXL tyrosine kinase receptors in thyroid cancer.
Avilla E; Guarino V; Visciano C; Liotti F; Svelto M; Krishnamoorthy G; Franco R; Melillo RM
Cancer Res; 2011 Mar; 71(5):1792-804. PubMed ID: 21343401
[TBL] [Abstract][Full Text] [Related]
26. TYRO3 as a molecular target for growth inhibition and apoptosis induction in bladder cancer.
Dufour F; Silina L; Neyret-Kahn H; Moreno-Vega A; Krucker C; Karboul N; Dorland-Galliot M; Maillé P; Chapeaublanc E; Allory Y; Stransky N; Haegel H; Menguy T; Duong V; Radvanyi F; Bernard-Pierrot I
Br J Cancer; 2019 Mar; 120(5):555-564. PubMed ID: 30765874
[TBL] [Abstract][Full Text] [Related]
27. The GAS6-AXL signaling pathway triggers actin remodeling that drives membrane ruffling, macropinocytosis, and cancer-cell invasion.
Zdżalik-Bielecka D; Poświata A; Kozik K; Jastrzębski K; Schink KO; Brewińska-Olchowik M; Piwocka K; Stenmark H; Miączyńska M
Proc Natl Acad Sci U S A; 2021 Jul; 118(28):. PubMed ID: 34244439
[TBL] [Abstract][Full Text] [Related]
28. TAM-ing T cells in the tumor microenvironment: implications for TAM receptor targeting.
Peeters MJW; Rahbech A; Thor Straten P
Cancer Immunol Immunother; 2020 Feb; 69(2):237-244. PubMed ID: 31664482
[TBL] [Abstract][Full Text] [Related]
29. The role of TAM family receptors and ligands in the nervous system: From development to pathobiology.
Shafit-Zagardo B; Gruber RC; DuBois JC
Pharmacol Ther; 2018 Aug; 188():97-117. PubMed ID: 29514053
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic efficacy of Tyro3, Axl, and Mer tyrosine kinase agonists in collagen-induced arthritis.
van den Brand BT; Abdollahi-Roodsaz S; Vermeij EA; Bennink MB; Arntz OJ; Rothlin CV; van den Berg WB; van de Loo FA
Arthritis Rheum; 2013 Mar; 65(3):671-80. PubMed ID: 23203851
[TBL] [Abstract][Full Text] [Related]
31. The Gas6/TAM System and Multiple Sclerosis.
Bellan M; Pirisi M; Sainaghi PP
Int J Mol Sci; 2016 Oct; 17(11):. PubMed ID: 27801848
[TBL] [Abstract][Full Text] [Related]
32. Gas6 Prevents Epithelial-Mesenchymal Transition in Alveolar Epithelial Cells via Production of PGE
Jung J; Lee YJ; Choi YH; Park EM; Kim HS; Kang JL
Cells; 2019 Jun; 8(7):. PubMed ID: 31247991
[TBL] [Abstract][Full Text] [Related]
33. New Insights into the Role of Tyro3, Axl, and Mer Receptors in Rheumatoid Arthritis.
Pagani S; Bellan M; Mauro D; Castello LM; Avanzi GC; Lewis MJ; Sainaghi PP; Pitzalis C; Nerviani A
Dis Markers; 2020; 2020():1614627. PubMed ID: 32051695
[TBL] [Abstract][Full Text] [Related]
34. TAM receptors: A phosphatidylserine receptor family and its implications in viral infections.
Ghosh Roy S
Int Rev Cell Mol Biol; 2020; 357():81-122. PubMed ID: 33234246
[TBL] [Abstract][Full Text] [Related]
35. Mer tyrosine kinase promotes the survival of t(1;19)-positive acute lymphoblastic leukemia (ALL) in the central nervous system (CNS).
Krause S; Pfeiffer C; Strube S; Alsadeq A; Fedders H; Vokuhl C; Loges S; Waizenegger J; Ben-Batalla I; Cario G; Möricke A; Stanulla M; Schrappe M; Schewe DM
Blood; 2015 Jan; 125(5):820-30. PubMed ID: 25428221
[TBL] [Abstract][Full Text] [Related]
36. Identification of Gas6 as a ligand for Mer, a neural cell adhesion molecule related receptor tyrosine kinase implicated in cellular transformation.
Chen J; Carey K; Godowski PJ
Oncogene; 1997 May; 14(17):2033-9. PubMed ID: 9160883
[TBL] [Abstract][Full Text] [Related]
37. TAM receptor signaling in development.
Burstyn-Cohen T
Int J Dev Biol; 2017; 61(3-4-5):215-224. PubMed ID: 28621419
[TBL] [Abstract][Full Text] [Related]
38.
Saito T; Itoh M; Tohda S
Anticancer Res; 2022 Apr; 42(4):1757-1761. PubMed ID: 35346994
[TBL] [Abstract][Full Text] [Related]
39. Molecular profiling of TAM tyrosine kinase receptors and ligands in endometrial carcinoma: An in silico-study.
Dilara Fatma Akin ; Özkan D
Taiwan J Obstet Gynecol; 2023 Mar; 62(2):311-324. PubMed ID: 36965901
[TBL] [Abstract][Full Text] [Related]
40. Gas6 is complexed to the soluble tyrosine kinase receptor Axl in human blood.
Ekman C; Stenhoff J; Dahlbäck B
J Thromb Haemost; 2010 Apr; 8(4):838-44. PubMed ID: 20088931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
